Zoetis Plans to Keep Factories as It Seeks New Products

Zoetis Inc., the animal health company that gained 19 percent in its initial public offering yesterday, is developing new antibiotic medicines and doesn’t anticipate closing any of its 29 factories around the world.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.